Therapeutics: Clinical Trials

2,241 trials of Therapeutics, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1206 completed, 319 recruiting, 303 unknown, 122 not yet recruiting. 1524 Not applicable, 218 Phase 2, 116 Phase 1, 116 Phase 3, 115 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable1524Completed 833, Recruiting 224, Unknown 200, Not yet recruiting 81, Terminated 61, Active not recruiting 50, Withdrawn 42, Enrolling by invitation 31, Suspended 2
Phase 2218Completed 118, Recruiting 28, Unknown 23, Terminated 19, Not yet recruiting 15, Withdrawn 8, Active not recruiting 6, Suspended 1
Phase 1116Completed 71, Unknown 14, Terminated 13, Recruiting 9, Not yet recruiting 5, Active not recruiting 3, Withdrawn 1
Phase 3116Completed 73, Recruiting 11, Unknown 11, Terminated 10, Not yet recruiting 6, Active not recruiting 2, Enrolling by invitation 1, Suspended 1, Withdrawn 1
Phase 4115Completed 54, Recruiting 17, Unknown 16, Not yet recruiting 12, Terminated 7, Withdrawn 6, Active not recruiting 2, Enrolling by invitation 1
Early Phase 117Completed 9, Unknown 3, Active not recruiting 2, Recruiting 2, Terminated 1

Follow Therapeutics: new trials by email Literature Review of Therapeutics trials Research Report on Therapeutics

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Collaborative Care Intervention for Cancer Patients and Their Family Caregivers -LITE
Stepped collaborative care intervention, Enhanced Usual Care - Cancer, Depression
Not applicableNot yet recruitingUniversity of Pittsburgh402028-01-142026-04-09
Digital Self-help Program for Functional Hypothalamic Amenorrhea (HEAL-FHA RCT)
Psychoeduation for FHA, Treatment as Usual (TAU) - Hypothalamic Amenorrhea, Functional
Not applicableNot yet recruitingKarolinska Institutet702027-09-012026-11-12
Evaluation of the Acceptability, Feasibility and Exploration of the Efficacy of an Integrated Care Pathway CARIBOU
CARIBOU Integrated Care Pathway, Treatment as Usual (TAU) - Major Depressive Disorder (MDD)
Not applicableNot yet recruitingUniversidad de los Andes, Chile722027-07-012026-10-20
Feasibility Trial of a Parent Peer-Co-Led Caregiver Group for Pediatric Early Onset Schizophrenia Spectrum Disorders
Group Therapy, Treatment as Usual (TAU) - Schizophrenia; Psychosis
Not applicableNot yet recruitingBoston Children's Hospital202027-05-012026-10-09
A Trial of the Arctx Cool Catheter in Acute Pancreatitis
Treatment, Control - Acute Pancreatitis (AP)
Not applicableNot yet recruitingArctx Medical, Inc.2002027-02-012026-09-03
Family-partnered Delirium Prevention, Detection, and Management in the ICU
Standard of Care, Delirium Education, Prevention, and Management - Delirium, Intensive Care Unit Delirium
Not applicableNot yet recruitingUniversity of Calgary13442027-02-012026-10-27
Subcutaneous Blinatumomab Plus Ponatinib for BCR-ABL+ B-ALL
Treatment with blinatumomab given subcutaneously. - Acute Lymphoblastic Leukemia (ALL) Philadelphia Chromosome-positive (Ph+), BCR-ABL Positive Acute Lymphoblastic Leukemia
Phase 2Not yet recruitingUniversity of Alberta802027-01-022026-08-12
Evaluating the Hope@School Prevention Program
Hope@School, Treatment as usual - Mental Health Wellness 1
Not applicableNot yet recruitingKarolinska Institutet32202027-01-012024-04-11
Early Absenteeism Guide for Lifelong Education
Intervention , EAGLE, Treatment as usual (TAU) - Absenteeism, School Absenteeism
Not applicableNot yet recruitingLund University902027-01-012026-10-05
Linking Individuals Needing Care for Substance Use Disorders to Peer Coaches & Across INcarceration Settings
Virtual Peer Recovery Coaching, Treatment as Usual - Substance Use
Not applicableRecruitingEmory University5502027-01-012026-11-10
N-Acetylcysteine (NAC) in Primary Sclerosing Cholangitis (PSC)
N-Acetylcysteine (NAC) Treatment - Primary Sclerosing Cholangitis (PSC)
Phase 2Not yet recruitingBrigham and Women's Hospital152026-12-052026-11-16
Facilitating Transition to Recommended PTSD Treatment
Treatment As Usual, New Health Services Intervention - PTSD
Not applicableNot yet recruitingVA Office of Research and Development402026-12-012026-08-18
Open-label Placebo for Pain Management in Adolescents and Young Adults Undergoing Bernese Periacetabular Osteotomy
Open-Label Placebo, Treatment as usual - Periacetabular Osteotomy, Opiates
Not applicableRecruitingUniversity of California, San Francisco642026-12-012026-04-29
Pilot Trial of an Emotion Regulation and Executive Functioning Intervention for Self-Injurious Thoughts and Behaviors (SITBs) in Children
Treatment as usual (TAU), Preadolescent SITB Intervention - Self-injury, Suicidal Ideation and Behavior
Not applicableNot yet recruitingUniversity of Colorado, Denver522026-12-012026-07-29
Parenting-STAIR Modular for Military Fathers and OCONUS Families
Parenting-STAIR Modular (PSTAIR-M), Treatment as Usual (TAU) - Depressive Symptoms, Emotional Depression
Not applicableNot yet recruitingNew York University2432026-12-012026-09-30
Sucrosomial Vs Intravenous Iron for Preoperative Anemia
Treatment with oral sucrosomial iron, Treatment with intravenous iron - Anemia, Iron Deficiency Anemia
Phase 4WithdrawnUniversity of Rochester2026-12-012026-10-06
Autoantibody Reduction Therapy for Progressive Idiopathic Pulmonary Fibrosis
Therapeutic Plasma Exchange, Rituximab, Intravenous immunoglobulin - Idiopathic Pulmonary Fibrosis
Phase 2Not yet recruitingUniversity of Alabama at Birmingham522026-12-012026-10-20
Transcranial Magnetic Stimulation for Methamphetamine Use Disorder During Pregnancy
4- Week Dual-Target Transcranial Magnetic Stimulation (TMS), Accelerated Dual-Target Transcranial Magnetic Stimulation (aTMS), Treatment as Usual (TAU) - Methamphetamine Use Disorder, Pregnancy
Not applicableNot yet recruitingUniversity of Utah452026-12-012026-11-05
The EYERISING Study
Repeated Low-Level Red Light (RLRL) therapy, Placebo Device - Myopia, Astigmatism
Not applicableNot yet recruitingUniversity of Wisconsin, Madison3332026-12-012026-11-05
BRIGHT-LIGHT: Studying Red Light Therapy for Severe Short-Sightedness or Short-Sightedness That Worsens Despite Standard Treatment
Repeated low-level red-light (RLRL) therapy, Continued existing myopia treatment strategy - Myopia, Myopia Progressing
Not applicableNot yet recruitingSingapore National Eye Centre402026-12-012026-11-06

Showing 20 of 2241. Sign in to see all of them.

Conditions studied

Depression (228)  ·  Anxiety Disorders (128)  ·  Stress Disorders, Post-Traumatic (102)  ·  Substance-Related Disorders (102)  ·  Schizophrenia (83)  ·  Psychotic Disorders (67)  ·  Mental Disorders (65)  ·  Depressive Disorder, Major (62)  ·  Breast Neoplasms (50)  ·  Chronic Pain (44)  ·  Neoplasms (43)  ·  Suicidal Ideation (43)  ·  Fatigue (41)  ·  Opioid-Related Disorders (41)  ·  Pain (40)

Sponsors

VA Office of Research and Development (38)  ·  University of Pittsburgh (28)  ·  Karolinska Institutet (27)  ·  BTL Industries Ltd. (21)  ·  Medical University of South Carolina (19)  ·  University of Washington (19)  ·  Yale University (19)  ·  Centre for Addiction and Mental Health (15)  ·  Resilient Pharmaceuticals (14)  ·  The University of Texas Health Science Center, Houston (13)  ·  NYU Langone Health (12)  ·  Norwegian University of Science and Technology (12)  ·  Shanghai Mental Health Center (12)  ·  Stanford University (12)  ·  University of South Florida (12)

Countries

United States (868)  ·  Canada (125)  ·  China (104)  ·  France (101)  ·  Spain (97)  ·  United Kingdom (90)  ·  Germany (84)  ·  Italy (73)  ·  Sweden (70)  ·  Denmark (68)  ·  Norway (65)  ·  Netherlands (43)  ·  Switzerland (42)  ·  Israel (39)  ·  South Korea (37)

Top investigators

Betty Ferrell, PhD (4)  ·  Jennifer Dahne, PhD (4)  ·  Craig J Bryan, PsyD, ABPP (3)  ·  Eric A Storch, Ph.D. (3)  ·  Johan Bjureberg, PhD (3)  ·  Marcia Grant, RN, DNSc, FAAN (3)  ·  Michael C Mithoefer, MD (3)  ·  Olivia Ojala, PhD (3)  ·  Silje E Reme, PhD (3)  ·  Albert Feliu, PhD (2)  ·  Alejandro Interian, PhD (2)  ·  Amy M Moore, MD (2)

Results publications

PMID 32368793, PMID 27488181, PMID 34874888, PMID 38819882, PMID 41766528, PMID 31065731, PMID 31572236, PMID 32500209, PMID 33677832, PMID 33884617, PMID 40342086, PMID 26083430, PMID 32779730, PMID 32880104, PMID 34658014, PMID 34693989, PMID 34752208, PMID 35420700, PMID 35636689, PMID 36356712, PMID 38509495, PMID 42755118, PMID 10125443, PMID 10231213, PMID 10332020, PMID 10571434, PMID 10660394, PMID 10686977, PMID 10733687, PMID 10742367, PMID 10870204, PMID 10996924, PMID 11016567, PMID 11188984, PMID 11254763, PMID 11257737, PMID 11295729, PMID 11299481, PMID 11350323, PMID 11438246, PMID 11704164, PMID 11780880, PMID 11897431, PMID 11971127, PMID 11978924, PMID 12377323, PMID 12436398, PMID 12467365, PMID 12534517, PMID 12689742

NIH funding

2019 (12), 2023 (9), 2025 (9), P30CA033572 (7), 2015 (4), 2018 (4), P30CA043703 (4), P30CA068485 (4), P01CA136396 (3), P50MH115838 (3), 2016 (2), 2017 (2), P20GM109040 (2), P30AG022845 (2), P30CA006927 (2)